Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities

Ravi Kalhan,1 David Slade,2 Riju Ray,2 Chad Moretz,3 Guillaume Germain,4 François Laliberté,4 Qin Shen,5 Mei Sheng Duh,6 Sean Dale MacKnight,4 Beth Hahn3 1Asthma and COPD Program, Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medic...

Full description

Bibliographic Details
Main Authors: Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:International Journal of COPD
Subjects:
copd
lama/laba
medical costs
comorbidities
severe exacerbations
Online Access:https://www.dovepress.com/umeclidiniumvilanterol-compared-with-fluticasone-propionatesalmeterol--peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/umeclidiniumvilanterol-compared-with-fluticasone-propionatesalmeterol--peer-reviewed-fulltext-article-COPD

Similar Items